SAMHSA-Certified Laboratory: What It Means, Who Needs One, and How to Verify Status

A “SAMHSA-certified laboratory” is a drug-testing laboratory that has been certified by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) under its National Laboratory Certification Program (NLCP) to perform forensic drug testing on specimens collected under the federal Mandatory Guidelines for Federal Workplace Drug Testing Programs. For procurement and compliance teams evaluating a drug-testing vendor, “SAMHSA-certified” is a specific, checkable regulatory status — not a generic marketing claim — and confirming it correctly is the single most important step before signing a testing contract that has any federal, DOT-regulated, or federal-contractor nexus.

What “SAMHSA-Certified Laboratory” Actually Means

SAMHSA does not test specimens itself. It certifies (and continues to monitor) private and public laboratories that meet the scientific, quality-control, and forensic chain-of-custody standards set out in the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs — the regulatory framework created under Executive Order 12564 (1986) and the Drug-Free Workplace Act of 1988 that governs drug testing of federal employees and, by extension, safety-sensitive transportation workers regulated under U.S. Department of Transportation (DOT) rules.

A laboratory earns and keeps NLCP certification by demonstrating, on an ongoing basis, that it can:

• Perform initial (immunoassay) screening and confirmatory testing (gas chromatography/mass spectrometry or liquid chromatography-tandem mass spectrometry) for the federally specified drug panel, using SAMHSA-specified cutoff concentrations.
• Maintain a documented, unbroken forensic chain of custody for every specimen, from collection through result reporting, sufficient to withstand legal and administrative challenge.
• Pass recurring unannounced on-site inspections conducted by SAMHSA-approved inspectors.
• Pass recurring blind proficiency testing (PT) — SAMHSA sends specimens of known composition through the lab’s normal testing pathway, disguised as ordinary samples, to confirm results are accurate without the lab knowing it is being evaluated.
• Employ a Laboratory Director and Certifying Scientists meeting SAMHSA’s specific qualification requirements, and correct any deficiency identified during inspection or PT within a defined corrective-action period.

Certification is specimen-type specific. Historically NLCP certification covered urine testing only; SAMHSA has since also established Mandatory Guidelines and a certification pathway for oral fluid testing, so “SAMHSA-certified” for a given lab should be read as certified for a specific specimen type, not certified in the abstract — verify which matrix (urine, oral fluid, or both) a prospective vendor is actually certified for.

The Regulatory Basis: HHS Mandatory Guidelines and the NLCP

The Mandatory Guidelines are published by HHS (through SAMHSA) in the Federal Register and apply directly to: federal executive agencies testing their own employees, and — via incorporation into 49 CFR Part 40 — safety-sensitive employees in DOT-regulated industries (aviation, trucking/commercial motor vehicles, rail, transit, pipeline, and maritime). 49 CFR Part 40 requires that any specimen collected for a DOT-regulated test be analyzed only by a laboratory certified by HHS/SAMHSA under the NLCP. This is the practical reason “SAMHSA-certified” shows up so often in transportation, federal-contractor, and regulated-industry procurement conversations: for that testing population, using a non-certified lab is not a quality preference, it is a compliance failure.

Outside those mandated populations, many private employers and state programs voluntarily require or prefer a SAMHSA-certified lab anyway, because the certification bundles together forensic chain-of-custody rigor, methodology validation, and independent third-party oversight that is difficult to replicate through a purely internal quality program.

Who Actually Needs to Use One

• Federal agencies testing their own workforce under Executive Order 12564.
• DOT-regulated employers (and their consortium/third-party administrators) testing safety-sensitive employees under 49 CFR Part 40 — this use is mandatory, not optional.
• Federal contractors and grantees whose award terms or agency-specific drug-free workplace requirements reference the Mandatory Guidelines.
• State and local government employers where state law mirrors or references the federal Mandatory Guidelines for public-safety or licensed-profession testing.
• Private employers who are not legally required to but choose SAMHSA certification as a procurement floor for defensibility in litigation or arbitration over a positive result.

SAMHSA Certification vs. Other Lab Certifications: How Not to Confuse Them

Procurement teams sourcing “lab certification” frequently conflate several genuinely different credentials that happen to share vocabulary. They are not interchangeable, and a lab can hold one, several, or none of them independent of the others:

Credential	What it actually certifies	Administered by	Relevant when
SAMHSA / NLCP certification	Forensic drug testing under the federal Mandatory Guidelines (specific drug panel, cutoffs, chain of custody)	SAMHSA (HHS)	DOT-regulated testing, federal workforce testing, any program that requires legally defensible forensic drug results
CLIA certification	General clinical laboratory testing quality (any test performed on a human specimen for diagnosis, treatment, or health assessment), organized by complexity category	CMS, under 42 CFR Part 493	Any clinical lab performing patient testing, including many drug-testing labs for their non-forensic diagnostic work — a lab can be CLIA-certified without being SAMHSA-certified, and vice versa
CAP or similar forensic/toxicology accreditation	Voluntary quality-system accreditation against a professional-body standard (e.g., forensic urine drug testing programs), addressing many of the same quality elements as NLCP	Accrediting body (e.g., College of American Pathologists)	Additional assurance layered on top of, not a substitute for, SAMHSA certification where SAMHSA certification is legally required
ISO/IEC 17025 accreditation	General testing/calibration laboratory competence management system, not specific to drug testing	Accreditation bodies such as A2LA or ANAB	Common in forensic toxicology and environmental labs as a general quality-system credential alongside, not instead of, program-specific certifications
State drug-testing lab licensure	State-level permit to operate, requirements vary by state	State health department or equivalent	State-regulated employer testing programs; requirements are separate from and additional to federal certification

The most common procurement mistake is treating CLIA certification as equivalent coverage for a federally mandated drug-testing program. It is not: CLIA addresses general clinical-testing quality, not the forensic chain-of-custody and drug-panel-specific requirements the Mandatory Guidelines impose. See CASRAI’s CLIA certification guide for how that credential works and when it does (and doesn’t) apply.

Drug Testing Lab Certification: The Full Landscape

“Drug testing lab certification” means different things depending on what is actually being tested and why, and a procurement officer should identify which category applies before evaluating vendors:

• Federal/DOT-mandated workplace testing — requires SAMHSA/NLCP certification specifically; no substitute credential satisfies 49 CFR Part 40.
• Employer drug-free-workplace testing (non-federally-mandated) — SAMHSA certification is not legally required but is the de facto industry benchmark most third-party administrators and testing consortiums default to, because of the forensic rigor and legal defensibility it provides.
• Clinical/diagnostic drug screening (e.g., pain-management monitoring, hospital toxicology) — governed by CLIA, not SAMHSA; the goal is patient care, not forensic defensibility, and different quality controls apply.
• Court-ordered or criminal-justice forensic toxicology — typically requires the receiving lab to hold forensic accreditation (e.g., ANAB/ASCLD-recognized programs) in addition to or instead of SAMHSA certification, depending on jurisdiction and what the testing is for.

Because these categories are governed by different bodies with different standards, a lab’s marketing material describing it as “certified” is not sufficient due diligence on its own — confirm certification against the specific program that actually governs the testing being procured.

Procurement Checklist: Verifying a SAMHSA-Certified Lab Before Contracting

1. Confirm current NLCP status directly with SAMHSA, not solely from the vendor’s own claim. SAMHSA publishes and periodically updates its list of currently certified laboratories; certification status can change (labs are added, and certification can be revoked or suspended for cause), so a vendor’s website claim should be checked against SAMHSA’s current published list, not assumed to be permanent once granted.
2. Confirm which specimen type(s) the certification covers — urine, oral fluid, or both — and make sure it matches what your program actually needs to collect and test.
3. Ask for the lab’s most recent NLCP inspection and proficiency-testing outcome, and whether any corrective actions are open. A certified lab can still have an active corrective-action item; ask directly rather than assuming certified means zero findings.
4. Verify chain-of-custody documentation and collection-site network meet your program’s needs — certification covers the laboratory’s analytical and forensic process, not the quality of the specimen-collection sites feeding it, which is a separate vendor-management question (collector training, custody-and-control form handling, specimen transport security).
5. If DOT-regulated testing is involved, confirm the lab’s certification specifically satisfies 49 CFR Part 40 requirements for the relevant modal agency (FMCSA, FAA, FRA, FTA, PHMSA, or USCG) — certification itself is uniform, but contract terms and reporting workflows (e.g., use of a DOT-compliant Medical Review Officer) still need to be verified separately.
6. Confirm reporting and result-review workflow, including how the lab interfaces with your Medical Review Officer (MRO), since a SAMHSA-certified lab reports results to an MRO for verification rather than releasing raw results directly to the employer.
7. Ask how other quality credentials (CLIA, ISO 17025, state licensure) are held, if relevant to your program, and confirm they are documented separately from SAMHSA status — do not accept one as a substitute for another.

Frequently Asked Questions

Is SAMHSA certification required for all drug testing?

No. It is legally required specifically for DOT-regulated safety-sensitive employee testing (49 CFR Part 40) and for federal agency workforce testing. Many private, non-federally-regulated employers use SAMHSA-certified labs voluntarily because the certification is widely treated as the credibility benchmark for forensically defensible drug testing, but it is not a universal legal requirement for every workplace drug test.

How is drug testing lab certification different from CLIA certification?

CLIA (42 CFR Part 493, administered by CMS) certifies general clinical laboratory testing quality across any human specimen testing used for diagnosis or treatment, organized by test-complexity category. SAMHSA/NLCP certification is specific to forensic drug testing under the federal Mandatory Guidelines, with its own chain-of-custody, methodology, and proficiency-testing requirements. A laboratory can hold either, both, or neither — they answer different regulatory questions. See CASRAI’s CLIA certification guide for the clinical-testing side of this distinction.

Where can I verify whether a lab is currently SAMHSA-certified?

SAMHSA maintains and periodically updates a published list of currently NLCP-certified laboratories. Because certification status can change, procurement and compliance staff should check the current list directly at the time of vendor evaluation and periodically during the contract term, rather than relying on a one-time check at onboarding.

Does SAMHSA certification cover oral fluid drug testing, or only urine?

SAMHSA’s original Mandatory Guidelines and NLCP program covered urine testing; SAMHSA has since also established Mandatory Guidelines and a certification pathway for oral fluid testing. Confirm which specimen type a specific lab’s certification actually covers — the two are certified separately, and a lab certified for one is not automatically certified for the other.

What happens if we use a non-SAMHSA-certified lab for DOT-regulated testing?

Testing performed outside a SAMHSA-certified laboratory does not satisfy 49 CFR Part 40 for DOT-regulated safety-sensitive employees, exposing the employer to compliance findings from the relevant DOT modal agency. This is a program-design question to resolve before contracting, not something to discover during an audit.